boehringer ingelheim glp-1 Boehringer's dual agonist survodutide shines in phase III trial | News GLP-1 Receptor Agonists and Research
Description
Studies in animals show GLP1 activation can reduce seeking of things like sugary food, alcohol, nicotine, and even cocaine
JAMA (2022) 327:138
Another limitation in comparing these retrospective studies is the inconsistency in the outcomes by which the association of GLP-1RAs with DR was measured
Many worry that the state is now holding obesity to a different standard than cancer or heart disease
Chesser AS, Pritchard SM, Johnson GV
